Deliberations of the 23 rd IEAG 13 - 14 July 2011.

Slides:



Advertisements
Similar presentations
1 June 2011 Measles update- India Dr. Satish Kumar Gupta Health Specialist UNICEF- India 13 th September 2011.
Advertisements

1 Dr. Azhar Abid Raza Washington Sept 2011 Measles elimination in Pakistan.
Managing OPV supplies in India
Module 1 Introduction to the polio endgame rationale and IPV vaccine
IPV IPV Rapidly produces high level of protective antibodies No risk of vaccine associated illness No interference from other enteroviruses. I.P.V. produces.
Monitoring progress towards the coverage and disease incidence targets GLOBAL MEASLES AND RUBELLA MANAGEMENT MEETING March 2011 Geneva, Switzerland.
Measles outbreak investigation & Response Jordan DR MOHAMAD RATIB SUROUR NATIONAL EPI MANAGER INTER-COUNTRY MEETING ON MEASLES AND RUBELLA CONTROL AND.
Supporting Routine AND Supplementary Immunization Activities in STOP.
Module 5 Recording and monitoring uptake of Inactivated Polio vaccine (IPV) Training for Inactivated Poliovirus Vaccine (IPV) introduction.
WHO RAP Team: Perspective and Update WORKSHOP ON ANALYZING THE POLIO ERADICATION ENDGAME, Seattle, 1-2 July 2015.
Global Polio Eradication Initiative Surveillance, Operation and Monitoring Vaccine Procurement, Communication and Social Mobilization Advocacy, Funding.
Completing The Endgame Global Polio Eradication
World Health Organization
Polio eradication programme in India – Progress, Response and Issues for action Dr Ajay Khera Deputy Commissioner Ministry of Health & FW, Govt. of India.
Routine Immunization: R ecent initiatives and progress in high risk areas 23 rd India Expert Advisory Group July, 2011 Dr Pradeep Haldar, MoHFW,
The Evolving 'Polio Endgame' Strategy
Conclusions & Recommendations 24 th IEAG March 2012.
Polio Update Pre Tender Meeting 11 th December 2008 UNICEF Supply Division.
Progress towards Sustainable Measles Mortality Reduction South-East Asia Region Jayantha Liyanage Medical Officer- EPI Immunization and Vaccine Development.
Progress & Challenges in Polio Eradication in Bihar Mr. Sanjay Kumar Secretary, Health 23 rd IEAG Meeting New Delhi.
Emergency Preparedness and Response Plan Dr. Ajay Khera Deputy Commissioner Ministry of Health & FW, Government of India.
Inter-Departmental Working Group
Completing Polio Eradication in Bihar 24 th January.
Update on the Implementation of Measles 2 nd Dose in India Ms. Anuradha Gupta Joint Secretary, Ministry of Health Govt. of India Global Measles and Rubella.
PolioPlus Progress Last wild poliovirus type 2 in the world Aligarh, India.
EPIDEMIOLOGY DENGUE, MALARIA Priority Areas for Planning Dengue Emergency Response 1. Establish a multisectoral dengue action committee.
1 Progress Towards Polio Eradication in EMR. 2 Status of global eradication Priority countries (except EMR) : Intensification : Certification,
Current Status of Immunization Service Delivery in Africa Mary Harvey AFR/SD/HRD SOTA/PHN Meeting June 13, 2002.
Update on Measles Mortality Reduction Activities and Linkages with RI.
Emergency Preparedness and Response Planning for Polio Dr N K Sinha State Immunization Officer State Health Society, Bihar.
Progress of Polio Eradication in India, Current Risks & Actions taken on last IEAG report 24 th IEAG, New Delhi 15 March 2012 Dr. Ajay Khera Deputy Commissioner.
Deliberations of the IEAG November IEAG Issues – Federal & State Gov'ts Why isn't epidemiology for type 1 and type 3 fully meeting IEAG projections.
Polio Eradication and End Game Strategy
JAHSR TECHNICAL REVIEW MEETING EPI Report Dr Dafrossa C Lyimo Programme Manager 7th September 2010 Dar es salaam.
Measles elimination Dr. As’ad Ramlawi Palestine..
1 1 Bose: SEAR Highlights and Priorities Global Measles & Rubella Management Meeting Geneva, March 2011 Accelerated Measles Control: Highlights and.
Governments of the World Present Status Leadership & Commitments New Funding Opportunities.
AGENDA AGENDA Twenty -Third Meeting of the India Expert Advisory Group (IEAG) for Polio Eradication July 2011, Hotel Taj Mahal, Mansingh Road, New.
Sustaining Polio Eradication IEAG March 2012 The experience of polio-free countries with importations of WPV: Implications for India.
Polio Eradication -- Global Progress and Development of Post-Eradication Strategies: Implications for U.S. Stockpile and Outbreak Response Preparations.
Global Overview of Measles & Rubella 11 th Annual Meeting The Measles Initiative Washington, DC th September, 2012.
PolioPlus: Keep our Promise to Eradicate Polio PolioPlus: Keep our Promise to Eradicate Polio.
Governments of the World New Tools and Tactics New Leadership & Commitments.
Withdrawal of OPV type 2 in India
Polio Endgame Strategy in India Considerations and Way Forward WHO-India, NPSP 15 March 2012.
1 Polio Strategic Plan India Expert Advisory Group July 2011 Impact & prospects at the half-way point.
Supplementary Immunization Activities Quality, Risks and Risk Management IEAG Meeting 13 July 2011.
TITLE PolioPlus Update ICC Meeting Amy Edwards 2 October.
Emergency Preparedness in Haryana Dr Suresh Dalpath DDCH / SEPIO Haryana.
Eradication of Poliomyelitis Global & National Overview Goal : Complete interruption of wild poliovirus transmission Dr OR Goldie (State EPI Officer Punjab)
India: Transitioning of Polio Network to Support Other Immunization Activities Jeffrey W McFarland, MD Regional Advisor, WHO South-East Asia Regional Office.
Global Polio Eradication Initiative The 'Intensified Effort' 18 May 2008.
Situation overview and Meeting Objectives The Middle East Polio Outbreak Phase II Review.
Supplementary Immunization Activities Quality, Coverage of high risk populations/ areas, proposed plans for IEAG Meeting 15 March 2011.
Emergency Preparedness and Response Planning Uttar Pradesh 24 th IEAG 15 – 16 March 2012 Director General, Family Welfare Govt. of UP.
Polio Research Activities in India Dr Sunil Bahl WHO-India, NPSP 15 March 2012.
Poliovirus Surveillance and Risks to Polio Eradication in India Dr. Hamid Jafari WHO-NPSP.
Emergency Preparedness Status in Maharashtra (IEAG July11) Dr D S Dakhure Director(H&FW-MH)
Poliovirus Surveillance status of quality, actions to improve sensitivity WHO-India 15 March 2012.
2015 Measles & Rubella Initiative Annual Partners Meeting, Human & Financial Costs of Measles and Rubella, 15 September 2015, Washington, DC Achieving.
February 2015 An introduction to the switch from trivalent to bivalent oral polio vaccines 1.
Module 1 Introduction to the polio endgame rationale and IPV vaccine
Situation of poliomyelitis in nepal, sear and globe
Targeted supplementary immunization
Perspective and Update
Global Polio Eradication: Current Status, Challenges and Future Directions Steven Wassilak, MD Centers for Disease Control and Prevention, Atlanta APHA.
Polio Eradication in Uttarakhand
Preparing for the Switch
Governments of the World. Governments of the World.
Polio Eradication Progress & Challenges.
Presentation transcript:

Deliberations of the 23 rd IEAG July 2011

Questions to the IEAG 1.What is the significance of the current polio epidemiology – is this progress real? 2.What are the implications of the ensuing high transmission season for the current polio situation? 3.What are the risks for continued polio transmission in India? 4.How should these risks be effectively addressed to ensure that the gains made so far are further consolidated to achieve polio eradication?

Questions to the IEAG 5.What should be the number, timing, scope and vaccine type for SIAs during the remaining months of 2011 and early 2012? 6.How should the current communication gains be maintained and what are the specific communication challenges at this stage of polio eradication? 7.How should the program begin to prepare for the next phase of polio eradication?

Q1: What is the significance of the current polio epidemiology – is this progress real?

A Snapshot of Polio Situation in India P1 wildP3 wild 1 case to date in 2011 vs. 24 cases at same point in serotype in 2011 vs. 2 in genetic cluster in 2011 vs 5 in No sewage WPV since Nov

WPV cases during previous 12 months, India N=2 Dec 2010 – June 2011* N=11 Jun 2010 – Nov 2010 N=0 N=7 Type 1 Polio Type 3 Polio West Bengal is the only state with wild virus in 2011

WPV1 cases in endemic states, Uttar Pradesh Bihar 2011* Longest indigenous WPV1 transmission free period simultaneously in both endemic states Cross-border transmission with Nepal

Q2: What are the implications of the ensuing high transmission season for the current polio situation?

IEAG Conclusion 2: There is a high risk that any residual or imported wild poliovirus will manifest between July & November.

Monthly incidence of WPV1 cases, High transmission season Any residual WPV transmission is likely to be detected in the coming high season for polio

Q3: What are the risks for continued polio transmission in India?

Undetected low season transmission Return of Indian viruses from Africa New importations from reservoirs Risks to India's US$1 Billion Investment in Polio Eradication

RISK 1: Undetected Virus within India Highest risk areas (a) historic reservoirs, (b) orphan virus areas, (c) recent/recurrent re- infected areas Districts with ‘Orphan’ viruses,

Rest of India (N= 48) Non epidemic UP* (N= 56) * non epidemic UP excludes Moradabad, JP Nagar, Badaun, Kanshiram Nagar, Bareilly and Rampur districts *Data as on 10 July 2011 RISK 2: Movement of Viruses in Migrants Migration status WPV1 cases,

Data in WHO HQ as of 14 Jun 2011 wild virus type 1 wild virus type 3 RISK 3: Importation of Viruses into India Polio-infected districts globally, last 6 months Virus that originated in India can return by the same routes!

Q4: How should these risks be effectively addressed to ensure that the gains made so far are further consolidated to achieve polio eradication?

4 essential elements of risk management: 1.enhance routine OPV3, esp. in west UP, WB 2.enhance surveillance 3.ensure outbreak preparedness plans 4.extra OPV campaigns in highest risk areas IEAG Conclusion 4:

Risk Mgmt 1: improve routine EPI, with priority to lagging reservoir & 'amplification' areas, building on recent best practices (e.g. session & community monitoring activities) RI Augmentation Muskan % Full Immunization coverage Bihar

Routine Immunization: 1.Particular attention to those reservoir or amplication areas with lagging OPV3 (e.g. west UP, West Bengal). 2.Re-emphasize critical importance of ANM and Medical Officer vacancies in these areas. 3.Continue to build on convergence of polio & routine EPI activities (e.g. microplanning, communications, migrant/marginalized pops). Risk Management 1

Surveillance: 1.complete the planned serosurvey (August) 2.expand environmental sampling as planned 3.enhance surveillance among migrant populations (e.g. enrolling appropriate reporting sites/informers) 4.sustain state-level reviews for quality assurance (esp. reservoirs/amplification areas) Risk Management 2

Howrah, 2011 Murshidabad, 2010 bOPVmOPV1 JanFebMarAprMayJunJulAugSepOctNovDec WPV1 notified 07 Feb 2011 WPV1 notified 12 Feb Number of WPV 5 weeks 17 weeks 1 week 7 weeks WPV1 WPV3 Risk Mgmt 3: build on best practices to refine WPV/cVDPV emergency preparedness plans

Emergency Preparedness Plans: 1.ensure all states complete plans & that these are shared/reviewed centrally 2.ensure the identified risk areas have follow-up risk mitigation activities 3.conduct simulation exercises in highest risk areas in August 2011 (reservoirs, recently infected areas & amplification sites) 4.Ensure minimum buffer stock of 40 million bOPV and 10 million tOPV doses (review 6 monthly) Risk Management 3

Q5: What should be the number, timing, scope and vaccine type for SIAs during the remaining months of 2011 and early 2012?

IEAG Conclusion 5: Additional OPV campaigns are essential to protect the 'reservoir' and 'amplication' areas going into the 2011 high season.

2011: additional OPV Campaign in August to reduce risk of high season amplification of any residual or imported virus SNID SepOctNovDecJulAug SepNov bOPV SNID Aug SNID

NID tOPV MarAprMayJunJanFeb SNID (bOPV) Endemic & risk states NID tOPV/bOPV SNID (bOPV) Endemic & risk states 2012: procure sufficient vaccine for aggressive OPV schedule in 1 st half of 2012, then prepone/postpone based on epidemiology SNID (bOPV) Endemic & risk states SNID (bOPV) Endemic & risk states

Q6: How should the current communication gains be maintained & what are the specific communication challenges at this stage of polio eradication?

IEAG Conclusion 6: The current plan to maintain communications gains is endorsed, recognizing that the greatest challenges are (a) ensuring rapid, high-quality emergency response & (b) building on the polio capacity to improve child health.

From Every Child, Every Time to Your Child, Every Time to My Child, Every Time New Personalized Branding of the Polio Communications Approach

1.Roll out the new communications approach (incl. major emphasis on routine immunization & other convergence messaging). 2.Sustain the SMNet in UP and Bihar, and consolidate capacity in West Bengal. 3.All states should have a media & IEC as key elements of WPV emergency response plans (incl. designated government spokesperson!) Recs: Communications

Q7: How should the program begin to prepare for the next phase of polio eradication?

IEAG Conclusion 7: Given the recent eradication progress, and the long timelines for post-eradication planning, this work should be intensified esp. in the absence of high season transmission.

1.intensify implementation of the Global Action Plan for Poliovirus Containment (targeting completion of phase 1 by end-2012) 2.accelerate research & product development agenda (e.g. mucosal immunity, mathematical modeling, safe & affordable IPV approaches) 3.consider convening special IEAG-NTAGI session in late 2011 Recs: Post-eradication planning

Conclusion

India is definitely on the right path to finish eradication. HOWEVER, a more aggressive approach is essential to manage the risks along this path!

Towards a polio-free India Rukhsar. Let's ensure she is the last polio case in India!